Company intelligence / Profile preview

Fenghua Biotech

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Fenghua Biotech is a Chinese medical technology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. The company focuses on point-of-care testing (POCT) solutions, offering a wide range of products for detecting infectious diseases, cardiac markers, and inflammatory indicators. Their portfolio includes fluorescence immunochromatography systems and various rapid test kits used in clinical settings. Fenghua Biotech serves both domestic and international markets, providing diagnostic tools for emergency rooms, ICUs, and primary healthcare facilities.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularInfectious DiseasesGastroenterology
Modalities: In vitro diagnosticsImmunoassayMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Fenghua Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenghua Biotech.

Explore the full profile